Sagetis Biotech, CataloniaBio & HealthTech member, granted an exclusive license to develop, manufacture and commercialise its polymeric coating technology Viroshield™ to French company Aratinga.

This technology is able to modify the behavior of oncolytic viruses, improving their therapeutic effect by different means.

Sagetis Biotech is also developing novel SAG-101, a polymer-coated adenovirus for the treatment of pancreatic ductal adenocarcinoma. It received orphan designation from the European Medicines Agency (EMA) in 2017.

More information

Photo: Eduard Diviu, CEO of Sagetis Biotech

The highly-regarded Transactional Track Record (TTR) has ranked RCD as the leading private equity and venture capital advisor according to the numbers from its 2019 first quarter report in the Iberian market. The firm also placed in the top spots for most active M&A advisors. These numbers continue the trend of recent years.

The RCD team is made up of 300 professionals specialized in 20 areas of legal and sectorial practice as life sciences sector.

More information

Photo: Partners of the Innovation and Entrepreneurship Department - © RCD

Transplant Biomedicals, CataloniaBio & HealthTech member, has completed patient enrolment of the clinical trial of Vivian® device for the transport and preservation of kidneys for transplantation. 

It is a multicenter and prospective study designed to evaluate the safety and performance of Vivian® in 32 patients of Hospital Clínic Barcelona, Vall d’Hebron University Hospital and Bellvitge University Hospital. Interim results are expected to be available next May and complete results in 1Q 2020.

“Vivian® has the profile of a true game changer in organ preservation market, and our development plan is poised to explore all these opportunities” says Dr. Joan ...

Vytrus Biotech, a CataloniaBio & HealthTech member, won three awards at the 2019 In-Cosmetics fair held from 2 to 4 April in Paris.

The latest ingredient launched to market by this Terrassa-based company, Olea Vitae, was named the most innovative product of the fair (Innovation Zone Best Active Ingredient Award). The active ingredient is obtained from the stem cells of olive trees and used to combat skin ageing.

In-Cosmetics also recognised the company's work in promoting the sustainability of its active ingredient Sarcoslim Reshape, which helps reduce fat, with the Green Award.

Finally, the publication Cosmetics Design gave the company ...

The Eurecat technology centre, member of CataloniaBio & HealthTech, and the Maresme Healthcare Consortium have developed a new medical product that avoids the appearance of prolonged pressure ulcers.

It is a protector with a 3D fabric and sock-like, easy to use, which makes it more comfortable for users than other solutions on the market. It is the brainchild of Dr Jesús Alòs, a vascular surgeon at Mataró Hospital.

Pressure ulcers on the foot are skin lesions caused by the application of constant pressure as a result of reduced mobility on the part of the patient.